1. Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor M, et al. The global burden of ischemic stroke: findings of the GBD 2010 study.
Glob Heart 2014;9:107-112.
2. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
Lancet 2016;388:1545-1602.
3. Zhou M, Wang H, Zhu J, Chen W, Wang L, Liu S, et al. Causespecific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013.
Lancet 2016;387:251-272.
4. Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults.
Circulation 2017;135:759-771.
5. Wang J, Wen X, Li W, Li X, Wang Y, Lu W. Risk factors for stroke in the Chinese population: a systematic review and meta-analysis.
J Stroke Cerebrovasc Dis 2017;26:509-517.
6. Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention.
Circ Res 2017;120:472-495.
8. Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012.
JAMA 2014;311:183-192.
9. Li S, Ma C, Xi B. Tobacco control in China: still a long way to go.
Lancet 2016;387:1375-1376.
10. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
Lancet 2016;388:761-775.
11. Hancock DB, Soler Artigas M, Gharib SA, Henry A, Manichaikul A, Ramasamy A, et al. Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function.
PLoS Genet 2012;8:e1003098.
12. Qi Q, Chu AY, Kang JH, Jensen MK, Curhan GC, Pasquale LR, et al. Sugar-sweetened beverages and genetic risk of obesity.
N Engl J Med 2012;367:1387-1396.
13. Jousilahti P, Rastenyte D, Tuomilehto J, Sarti C, Vartiainen E. Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland.
Stroke 1997;28:1361-1366.
15. Leander K, Hallqvist J, Reuterwall C, Ahlbom A, de Faire U. Family history of coronary heart disease, a strong risk factor for myocardial infarction interacting with other cardiovascular risk factors: results from the Stockholm Heart Epidemiology Program (SHEEP).
Epidemiology 2001;12:215-221.
16. Woo D, Khoury J, Haverbusch MM, Sekar P, Flaherty ML, Kleindorfer DO, et al. Smoking and family history and risk of aneurysmal subarachnoid hemorrhage.
Neurology 2009;72:69-72.
17. Chen Z, Lee L, Chen J, Collins R, Wu F, Guo Y, et al. Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC).
Int J Epidemiol 2005;34:1243-1249.
19. Liu X, Bragg F, Yang L, Kartsonaki C, Guo Y, Du H, et al. Smoking and smoking cessation in relation to risk of diabetes in Chinese men and women: a 9-year prospective study of 0·5 million people.
Lancet Public Health 2018;3:e167-e176.
20. Lee CR, North KE, Bray MS, Avery CL, Mosher MJ, Couper DJ, et al. NOS3 polymorphisms, cigarette smoking, and cardiovascular disease risk: the Atherosclerosis Risk in Communities study.
Pharmacogenet Genomics 2006;16:891-899.
21. Pezzini A, Grassi M, Del Zotto E, Bazzoli E, Archetti S, Assanelli D, et al. Synergistic effect of apolipoprotein E polymorphisms and cigarette smoking on risk of ischemic stroke in young adults.
Stroke 2004;35:438-442.
22. Szolnoki Z, Somogyvári F, Kondacs A, Szabó M, Fodor L, Bene J, et al. Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke.
J Neurol Neurosurg Psychiatry 2003;74:1615-1620.
23. Liu J, Cheng J, Peng J, Han S, Yu L, Nie S. Effects of polymorphisms of heat shock protein 70 gene on ischemic stroke, and interaction with smoking in China.
Clin Chim Acta 2007;384:64-68.
24. Gao X, Yang H, ZhiPing T. Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke.
Neurosci Lett 2006;398:172-177.
25. Cheng Q, Li YK, Lu F, Yin L, Wang YZ, Wei W, et al. Interactions between ACYP2 genetic polymorphisms and environment factors with susceptibility to ischemic stroke in a Han Chinese population.
Oncotarget 2017;8:97913-97919.
26. Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN. The influence of acute smoking on leucocytes, platelets and the endothelium.
Atherosclerosis 1998;141:133-139.
27. Barua RS, Ambrose JA, Saha DC, Eales-Reynolds LJ. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration.
Circulation 2002;106:905-908.
28. Nagy J, Demaster EG, Wittmann I, Shultz P, Raij L. Induction of endothelial cell injury by cigarette smoke.
Endothelium 1997;5:251-263.
29. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
Circulation 1999;99:1411-1415.
30. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
Eur Heart J 2005;26:1765-1773.
31. Renaud S, Blache D, Dumont E, Thevenon C, Wissendanger T. Platelet function after cigarette smoking in relation to nicotine and carbon monoxide.
Clin Pharmacol Ther 1984;36:389-395.
32. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco.
N Engl J Med 2014;370:60-68.